Westport Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.05M | Hold |
15,000
| – | – | 0.46% | 40 |
|
2025
Q1 | $1.1M | Hold |
15,000
| – | – | 0.53% | 37 |
|
2024
Q4 | $983K | Hold |
15,000
| – | – | 0.47% | 39 |
|
2024
Q3 | $1.17M | Hold |
15,000
| – | – | 0.55% | 35 |
|
2024
Q2 | $1.17M | Hold |
15,000
| – | – | 0.59% | 35 |
|
2024
Q1 | $1.02M | Hold |
15,000
| – | – | 0.51% | 37 |
|
2023
Q4 | $1.01M | Hold |
15,000
| – | – | 0.54% | 38 |
|
2023
Q3 | $1.02M | Hold |
15,000
| – | – | 0.6% | 38 |
|
2023
Q2 | $1.07M | Hold |
15,000
| – | – | 0.6% | 40 |
|
2023
Q1 | $1.04M | Hold |
15,000
| – | – | 0.63% | 38 |
|
2022
Q4 | $1.02M | Hold |
15,000
| – | – | 0.65% | 36 |
|
2022
Q3 | $823K | Hold |
15,000
| – | – | 0.52% | 39 |
|
2022
Q2 | $991K | Hold |
15,000
| – | – | 0.59% | 36 |
|
2022
Q1 | $874K | Hold |
15,000
| – | – | 0.4% | 45 |
|
2021
Q4 | $874K | Hold |
15,000
| – | – | 0.4% | 45 |
|
2021
Q3 | $901K | Hold |
15,000
| – | – | 0.44% | 42 |
|
2021
Q2 | $899K | Hold |
15,000
| – | – | 0.4% | 44 |
|
2021
Q1 | $746K | Hold |
15,000
| – | – | 0.34% | 46 |
|
2020
Q4 | $750K | Hold |
15,000
| – | – | 0.37% | 43 |
|
2020
Q3 | $822K | Hold |
15,000
| – | – | 0.5% | 37 |
|
2020
Q2 | $793K | Hold |
15,000
| – | – | 0.51% | 37 |
|
2020
Q1 | $670K | Hold |
15,000
| – | – | 0.55% | 36 |
|
2019
Q4 | $748K | Hold |
15,000
| – | – | 0.51% | 30 |
|
2019
Q3 | $669K | Hold |
15,000
| – | – | 0.48% | 33 |
|
2019
Q2 | $619K | Buy |
15,000
+5,000
| +50% | +$206K | 0.42% | 35 |
|
2019
Q1 | $404K | Hold |
10,000
| – | – | 0.28% | 43 |
|
2018
Q4 | $380K | Hold |
10,000
| – | – | 0.32% | 40 |
|
2018
Q3 | $350K | Hold |
10,000
| – | – | 0.25% | 43 |
|
2018
Q2 | $350K | Hold |
10,000
| – | – | 0.25% | 43 |
|
2018
Q1 | $350K | Hold |
10,000
| – | – | 0.25% | 42 |
|
2017
Q4 | $341K | Hold |
10,000
| – | – | 0.26% | 43 |
|
2017
Q3 | $341K | Buy |
10,000
+5,000
| +100% | +$171K | 0.26% | 44 |
|
2017
Q2 | $170K | Buy |
+5,000
| New | +$170K | 0.15% | 46 |
|